Propel Bio Management, LLC Applied Therapeutics Inc. Transaction History
Propel Bio Management, LLC
- $154 Billion
- Q2 2024
A detailed history of Propel Bio Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 6,567,858 shares of APLT stock, worth $54.3 Million. This represents 19.89% of its overall portfolio holdings.
Number of Shares
6,567,858
Previous 6,111,906
7.46%
Holding current value
$54.3 Million
Previous $41.6 Billion
26.2%
% of portfolio
19.89%
Previous 24.19%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
100Shares Held
103MCall Options Held
797KPut Options Held
80.8K-
Franklin Resources Inc San Mateo, CA10.2MShares$84.5 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY9.54MShares$78.9 Million4.89% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$66.2 Million1.08% of portfolio
-
Janus Henderson Group PLC London, X07.65MShares$63.3 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$54.3 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $397M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...